PNC Financial Services Group’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.7K Hold
12,043
﹤0.01% 3429
2025
Q4
$49K Hold
12,043
﹤0.01% 3228
2025
Q3
$42.8K Buy
12,043
+926
+8% +$3.35K ﹤0.01% 3297
2025
Q2
$30.3K Sell
11,117
-487
-4% -$1K ﹤0.01% 3367
2025
Q1
$19.5K Buy
11,604
+1,573
+16% +$4.4K ﹤0.01% 3551
2024
Q4
$16.4K Buy
10,031
+10,011
+50,055% +$29.9K ﹤0.01% 3622
2024
Q3
$83 Hold
20
﹤0.01% 4730
2024
Q2
$109 Buy
20
+13
+186% +$104 ﹤0.01% 4713
2024
Q1
$70 Buy
+7
New +$52 ﹤0.01% 4654
2023
Q3
Sell
-600
Closed -$3.58K 4731
2023
Q2
$3.58K Hold
600
﹤0.01% 4204
2023
Q1
$1.96K Hold
600
﹤0.01% 4317
2022
Q4
$2.37K Hold
600
﹤0.01% 4206
2022
Q3
$4K Hold
600
﹤0.01% 4033
2022
Q2
$4K Hold
600
﹤0.01% 4065
2022
Q1
$5K Sell
600
-45
-7% -$364 ﹤0.01% 4010
2021
Q4
$10K Hold
645
﹤0.01% 3794
2021
Q3
$15K Sell
645
-555
-46% -$11.7K ﹤0.01% 3623
2021
Q2
$24K Buy
1,200
+600
+100% +$13.6K ﹤0.01% 3398
2021
Q1
$20K Buy
+600
New +$19.5K ﹤0.01% 3416

Other funds holding SANA

PNC Financial Services Group's SANA Position: Q1 2026 in Review

PNC Financial Services Group held its Sana Biotechnology (SANA) position steady in Q1 2026 at 12,043 shares worth $34.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3429.

PNC Financial Services Group first reported a position in SANA in Q1 2021 and has held it in 19 quarters since. The position peaked at $49K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • PNC Financial Services Group held 12,043 shares of Sana Biotechnology worth $34.7K as of Q1 2026.
  • PNC Financial Services Group left its Sana Biotechnology share count unchanged in Q1 2026.
  • Sana Biotechnology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3429 holding.
  • PNC Financial Services Group first reported a position in Sana Biotechnology in Q1 2021 and has held it in 19 quarters since.
  • PNC Financial Services Group's Sana Biotechnology position peaked at $49K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.